| Typicality: | 0.401 |
| Saliency: | 0.355 |
| specifically | 6 | manner |
| in the immune system | 4 | location |
| of targeting cancer cells | 3 | manner |
| drug → target → cell | 31 |
| drug → target → specific cells | 8 |
| drug → target → human cells | 4 |
| negative | neutral | positive |
| 0.333 | 0.501 | 0.166 |
| Raw frequency | 43 |
| Normalized frequency | 0.355 |
| Modifier score | 0.500 |
| Perplexity | 257.142 |